Background: Previous studies have suggested that psychological interventions may be effective in reducing blood pressure. Using rigorous methodology and 24hour monitoring of ambulatory blood pressure, we compared 2 psychological interventions with treatment using a firstline antihypertensive drug in terms of their efficacy in lowering blood pressure in patients with mild primary hypertension.
P ATIENTS WITH MILD PRIMARY HYPERTENSION
have a number of options to help lower their blood pressure. Nonpharmacological options in clude the DASH (Dietary Approaches to Stop Hyperten sion) diet, 1 a lowsodium diet, 2 exercise, 3 weight loss 4 and relaxation therapies. 5 Relaxation therapies are based on the supposition that psychological stress may contribute to the elevation of blood pressure in some pa tients. 6, 7 Others have suggested possible links between stress and hypertension are elevated sympathetic tone or vagal dysregulation. 6, 8 Several systematic reviews have evaluated the efficacy of diverse psychological and relaxation therapies in reducing blood pressure in pa tients with primary hypertension as compared to no therapy or sham therapy. 5, 913 However, these studies have yielded conflicting results.
It remains important to determine whether psycholo gical interventions lower blood pressure and the mag nitude of the effect, if any, as many patients might prefer this form of therapy over drug therapy if both were equally efficacious. We were therefore interested in evaluating the efficacy of 2 psychological interven tions in lowering blood pressure: an individualized pro gram of behavioural therapy and a selfhelp program of psychological therapy.
With the objective of rigorously assessing the effects of these 2 psychological interventions, we compared them with pharmacotherapy using a thiazide, a first line drug commonly used in the treatment of mild primary hypertension. A large body of evidence from randomized controlled trials (RCTs) shows that thiazides reduce blood pressure and quantifies the mag nitude of their shortterm effect on systolic and diastolic blood pressure as about 9/4 mm Hg. 14 There is consider able value in using a drug with a known effect as a posit ive control for a study such as this one. As far as we know, no previous RCTs have directly compared psycho logical interventions with a drug therapy control.
Methods
Design. Prospective, openlabel, randomized controlled trial.
Setting and participants.
Adult patients (aged 18 years or older) from the community, with mild hypertension defined as resting systolic blood pressureof 140 mm Hg or above and/or diastolic blood pressureof 90 mm Hg or above, were eligible. Patients were excluded if they had cardiovascular complications or any suspected med ical condition that might lead to an unacceptable risk of complications resulting from uncontrolled hypertension during the study period. Patients whose hypertension was uncontrolled while they were taking medication (systolic blood pressure ≥ 170 mm Hg or diastolic blood pressure ≥ 100 mm Hg) or who had excessively high blood pressure while they were not taking any medica tion (≥ 180/110 mm Hg) were also excluded. Patients with suspected secondary hypertension were excluded, as were those who were pregnant or anticipated being pregnant and those with a history of allergy to, hyper sensitivity to, or intolerance of thiazides. Participants were encouraged not to adopt any other changes in life style, diet or exercise during the trial.
Protocol. Patients who were taking medication at the time of initial screening underwent a washout period of 3-5 weeks. Patients who met the inclusion criteria and whose offtreatment baseline resting systolic blood pressure in clinic was 140 mm Hg or above or whose resting diastolic blood pressure was 90 mm Hg or above were randomly assigned to receive 1 of the following in terventions for 12 weeks: (1) hydrochlorothiazide 12.5 mg/d initially and then 25 mg/d if systolic blood pres sure was 140 mm Hg or above or diastolic blood pres sure was 90 mm Hg or above after 4 weeks of treatment; (2) individualized behavioural psychother apy consisting of ten 1hour sessions with a psycholo gist; (3) selfhelp psychological therapy, consisting of an initial 1.5hour meeting with a psychologist and then daily sessions that involved reading a selfhelp manual and listening to an audiotape. Both of the psychological treatments entailed learning relaxation, biofeedback and stress management. Details of these psychological forms of management are presented in Box 1. Conceal ment of allocation was achieved by centralized random ization conducted via telephone by the Cochrane Hypertension Review Group coordinator at the Uni versity of British Columbia. This person was blinded to patients' identification and to characteristics other than sex and previous use of antihypertensive drugs. Inform ation about these 2 characteristics was needed to allow block randomization. The study protocol was reviewed and approved by the institutional ethical review board at the University of British Columbia (UBC). Written in formed consent was obtained from all patients.
Recruitment, clinical evaluation and follow-up. Par ticipants were recruited by means of newspaper advert ising and/or referral by health care practitioners or friends. This recruitment was coordinated by UBC's Be havioural Cardiology Laboratory (BCL). Patients who had not previously been receiving antihypertensive drugs but who exhibited elevated blood pressure at the BCL were sent to the hypertension medical clinic for confirmation of eligibility. Patients who were already taking antihypertensive drugs were seen at the laborat ory and were then sent to the clinic, where blood pres sure was measured before and after washout, with the possibility of a third postwashout check in the event of borderline blood pressure readings. All of these poten tial participants provided a medical history and under went a physical examination. A specific laboratory assessment was ordered if considered necessary. After enrolment, the patients attended the clinic every 4 weeks. At each visit, resting blood pressure was meas ured. All resting blood pressure measurements were re ported as the average of 5 readings, separated by 1minute intervals, with the first reading after 5 minutes of rest. The patient was in a seated position and the ex aminer was out of the room during the readings, which were obtained with an automatic device that concealed the measurements from the patient (oscillometric VSM 100 automated blood pressure machineVSM MedTech Ltd., Vancouver, BC, Canada 15 ). This rigorous methodo logy was intended to prevent any bias in the blood pres sure measurements. True blinding of the patients and investigators was not feasible in view of the type of inter ventions in this study. At week 7, serum levels of po tassium were checked for all of the patients who had been randomly assigned to receive hydrochlorothiazide, to detect hypokalemia, if present, and to allow the pre scription of a potassiumsparing diuretic if required. Patients were instructed to report to the clinic immedi ately if they experienced any unusual symptoms during the study.
Before treatment of any kind, each patient under went 24hour monitoring of ambulatory blood pressure, by means of the Spacelabs Medical ambulatory blood pressure monitor (model 90207, Spacelabs Inc, Red mond, Washington, USA). For this monitoring, blood pressure was recorded at 20minute intervals between 8:00 a.m. and 8:00 p.m. (for daytime measurements) and at 1hour intervals between 8:00 p.m. and 8:00 a.m. (for nighttime measurements). The monitoring was repeated 12 weeks later (i.e., at the end of the study).
Outcome measures. The primary outcome measure was the mean change in ambulatory blood pressure from baseline to week 12. The secondary outcome meas ure was the mean change in resting clinic blood pres sure, over 12 weeks of treatment. All adverse events, regardless of their nature, were documented, reviewed and reported to the ethics committee.
Statistical analysis. The calculation of the sample size was based on a previous study, 16 in which there was a 7 mm Hg (standard deviation 11 mm Hg) difference in systolic pressure between individualized behavioural psychotherapy and no treatment. We calculated that a sample size of 40 patients per treatment arm would provide 80% power at the α = 0.05 level for detection of the abovementioned difference in blood pressure. However, because of the potential for dropouts, the de sired sample size was increased to 50 patients per treat ment arm. The efficacy endpoints were analyzed according to the intentiontotreat principle. All statistic al analyses were performed using the statistical package NCSS 2007 (LLC, Kaysville, Utah, USA). Paired Stu dent's t test was used to compare variables with continu ous data before and after treatment within each group. Treatment groups were compared by analysis of vari ance using the general linear model approach for re peated measurements and Tukey's test for multiple comparisons. Using baseline values as covariates, ana lysis of covariance (ANCOVA) was also performed. A p value less than 0.05 was considered statistically signific ant.
Results
Study population. Recruitment for this singlecentre study began in March 2002 and ended in May 2006. Un fortunately, because of recruitment difficulties, the de sired sample size of 50 per group was not achieved. Of the 516 patients with suspected hypertension who were screened, 337 were not eligible because they did not meet the study's inclusion criteria at the initial screen ing. The reasons for not qualifying varied: past medical history, desire to choose a particular treatment, re quired commitment of time too great, inability to come to our centre (e.g., living far away), lack of interest in stress management or in the drug. The remaining 179 patients were sent to the medical hypertension clinic for evaluation. Of these, 13 patients decided not to particip ate after undergoing the evaluation. An additional 101 patients were ineligible for the following reasons: 65 pa tients did not meet the minimum blood pressure inclu sion criteria after the washout process, 8 patients had excessively high blood pressure (≥180/110 mm Hg), (Fig. 1). A total of 65 patients (with baseline characteristics as listed in Table 1 ) were randomly assigned to 1 of the 3 groups: 21 to receive hydrochlorothiazide, 23 to un dergo individualized behavioural psychotherapy, and 21 to perform selfhelp psychotherapy. Two patients in each group acknowledged that they had sought psycho logical or psychiatric help in the past. One of these pa tients (assigned to the hydrochlorothiazide group) had received selfhelp psychological therapy (in the form of a booklet). There was no statistically significant differ ence in the number of patients who had previously re ceived hydrochlorothiazide or any other antihypertensive drug. Except for systolic blood pres sure as recorded during 24hour ambulatory monitor ing, which was higher for those in the selfhelp psychotherapy group, the groups were similar with re spect to all variables (Table 1) . Six patients in the hydro chlorothiazide group, 6 in the individualized behavioural psychotherapy group, and 9 in the selfhelp psychotherapy group withdrew from the study or did not undergo the second 24hour monitoring of ambu latory blood pressure (at 12 weeks) (Fig. 1 ).
Primary outcome: change in ambulatory blood pressure (24-hour monitoring).
Hydrochlorothiazide pro duced a statistically significant reduction in both systolic and diastolic blood pressure during 24hour monitoring of ambulatory blood pressure, and this change was greater than the changes observed with either individualized behavioural or selfhelp psycholo gical therapy (systolic mean reduction ± standard error: −11.03 ± 2.53 v. −0.08 ± 2.38 v. −1.23 ± 2.83 mm Hg, respectively, p = 0.006; diastolic: −6.06 ± 1.56 v. 0.29 ± 1.47 v. −0.71 ± 1.75 mm Hg, respectively, p = 0.01; Table 2 ). Neither form of psychological therapy reduced ambulatory blood pressure, as measured by 24hour monitoring, relative to baseline.
Secondary outcome: change in resting clinic blood pressure. For this outcome, we included data from all patients with at least one blood pressure measurement after treatment and used the weighted average from all posttreatment blood pressure measurements for the analysis. As such, data were available for more parti cipants: 19 in the hydrochlorothiazide group, 18 in the individualized behavioural therapy group, and 16 in the selfhelp therapy group. In this analysis, both hydro chlorothiazide therapy and individualized behavioural psychotherapy were associated with a statistically signi ficant reduction (relative to baseline) in systolic and diastolic blood pressure ( Table 3 ). The extent of reduc tion in blood pressure was numerically greater in the group receiving hydrochlorothiazide than in the other 2 groups, but the mean change in resting clinic systolic or diastolic blood pressure over 12 weeks showed no statist ically significant difference among the 3 groups.
Adverse events. A total of 5 patients withdrew because of adverse events. Three participants experienced in tractable headache (1 patient in the hydro chlorothiazide group and 2 in the selfhelp therapy group). In all 3 cases, the headache subsided after with drawal from the study. One patient who was receiving hydrochlorothiazide withdrew because of a suspected al lergic reaction to the study medication (the patient stopped taking the drug at day 21 because of soreness in the tongue and lips). One patient in the selfhelp therapy group withdrew because of palpitations. In ad dition to these 5 withdrawals, 1 patient who was receiv ing 25mg of hydrochlorothiazide experienced hypokalemia, which was corrected by the addition of spironolactone. There were no serious adverse events during the trial.
Discussion
It has been hypothesized that psychological stress may contribute to the elevation of blood pressure in patients with primary hypertension, and, conversely, that psy chological therapy may lower blood pressure. However, these hypotheses have been called into question by the results of a recent Cochrane systematic review, in par ticular the results obtained when the analysis was lim ited to studies that used blinded outcome assessment. 5 In that review of relaxation therapies, 25 RCTs (n = 1198 patients) were evaluated. The authors concluded that the effect of these therapies in lowering blood pres sure was questionable because of the poor quality of the studies. In fact, when only trials using blinded outcome assessment were included (9 RCTs, n = 498 patients), there was no significant reduction in either systolic or diastolic blood pressure. 5 
Figure 1: Flow diagram for patients in the study
The current study is the first RCT to directly com pare psychological therapy with a standard pharmacolo gical antihypertensive treatment. The use of hydrochlorothiazide as a control worked well in this study. The drug lowered ambulatory blood pressure, as measured by 24hour monitoring, by about 11/6 mm Hg, which is similar to the reduction reported in a metaanalysis of other studies of standarddose thiazide given for a similar duration of therapy, 9/4 mm Hg. 14 This result demonstrates that the patients in this trial were representative of patients in other trials studying mild to moderate hypertension.
This study has shown that in a clinical setting where thiazide therapy lowered blood pressure by a magnitude similar to that expected, 2 psychological therapies did not have this effect. This difference in outcome was par ticularly evident from the blood pressure data obtained with 24hour monitoring. In particular, the individual ized behavioural therapy and selfhelp psychotherapy had no effect on 24hour ambulatory systolic or diastol ic blood pressure.
Hydrochlorothiazide also significantly lowered rest ing clinic blood pressure relative to baseline. In addi tion, individualized behavioural psychotherapy but not selfhelp psychotherapy produced a statistically signific ant change in resting clinic blood pressure from baseline. For this outcome, however, there was no stat istically significant difference among the groups. This lack of difference may have been due in part to the "placebo effect" commonly observed in studies that used inclinic measurements of blood pressure. The causes of this phenomenon are unknown, but participat ing in a study may offer the patient some reassurance (e.g., by having the doctor's full attention, by meeting a psychological need), which could be enough to reduce anxiety and stress or to provoke changes in attitudes, which in turn might improve blood pressure readings in the clinic setting. It is also possible that the individual ized behavioural psychotherapy helped patients to learn to relax in the clinic setting, which would have offset the "whitecoat effect." If so, this would be unlikely to have any clinical value, as there was no reduction in ambulat ory blood pressure as measured by 24hour monitoring. This study was a good demonstration of the value of such 24hour monitoring. A previous study provided evidence for the lack of a placebo effect in patients with mild to moderate hypertension when blood pressure was measured by 24hour monitoring. 17 The combina tion of a lack of the placebo effect and the large number of blood pressure measurements obtained increases the power of 24hour monitoring to identify a treatment ef fect, as occurred in this trial.
One of the strengths of this study was the proper ran domization as well as the foolproof method of conceal ing treatment allocation from the patients and the investigators. Two additional strengths were the use of an automated device for recording both ambulatory and clinic blood pressure, and the absence of the investigat ors at the time of measurement. The objective of this was to reduce subjective bias when measuring blood pressure. A further strength of this study was that all of the available results were used in the analysis, which prevented any reporting bias.
One limitation of this study was the small sample size, which was caused by difficulties in recruiting pa tients with newly diagnosed hypertension and by ex cluding a large number of previously treated patients who did not meet the blood pressure criteria after the washout period (65 [58%] of the 112 patients who un derwent washout). A second, related limitation was the high rate of patients unavailable for the primary out come analysis (6/21 [29%] from the hydro chlorothiazide group, 6/23 [26%] from the individualized behavioural psychotherapy group and 9/21 [43%] from the selfhelp therapy group). Because we did not achieve the desired sample size and because many patients withdrew after randomization, the study's power was lower than planned, and the probab ility of accepting the null hypothesis (i.e., type II or beta error) was increased. Our inability to find differences when we compared the 3 groups of clinic blood pres sure measurements is an example of this type II error. This loss of power, however, did not prevent detection of a difference between hydrochlorothiazide and either psychological intervention by 24hour ambulatory measurements. A third limitation was the chance find ing that baseline blood pressure in the selfhelp psycho therapy group was higher than that in the individualized behavioural psychotherapy group. This might have reduced the opportunity for the individual ized behavioural psychotherapy intervention to lower blood pressure in that group. However, when we per formed the posthoc ANCOVA analysis using baseline values as a covariate, the p values changed minimally for both ambulatory and resting clinic blood pressure outcomes; we therefore believe that the initial differ ence in blood pressure between these 2 groups probably had little effect. Nonetheless, caution is warranted in interpreting these results, as the trial had limited power to prove a lack of effect of the psychological interven tions on the 24hour blood pressure measurements. When we planned our study, no information was avail able on the effect of psychological therapy in lowering blood pressure relative to a pharmacological treatment. We chose hydrochlorothiazide because, in addition to the wellknown ability of this drug to lower blood pres sure, the thiazides in general have the most evidence for reductions in mortality and morbidity when used as firstline drugs. 18 The key important finding of this study is that compared with hydrochlorothiazide, psy chological therapies appeared to have no clinically im portant effect in lowering blood pressure over a 12week period, as assessed by 24hour ambulatory monitoring. These results apply to patients with mild uncomplicated hypertension (systolic ≥ 140 and/or diastolic ≥ 90 mm Hg).
This new information needs to be put into context with other available RCT data. The best available evid ence of the effect of relaxation therapies on blood pres sure was provided by a recent Cochrane systematic review. In that review, Dickinson and colleagues 5 found that when only RCTs with blinded blood pressure meas urement were included, the psychological or relaxation techniques had no statistically significant effect in redu cing blood pressure. This led the authors to conclude, "In view of the poor quality of included trials and unex plained variation between trials, the evidence in favor of causal association between relaxation therapy and blood pressure reduction is weak. Some of the apparent benefit of relaxation was probably due to aspects of treatment unrelated to relaxation." 5 The results of the RCT presented here are in agreement with that conclu sion. If future trials of psychological interventions and other relaxation therapies are conducted, they must have rigorous designs to minimize bias.
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